Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antiviral activity of berberine
Alicja Warowicka, Robert Nawrot, Anna Goździcka‐Józefiak
Archives of Virology (2020) Vol. 165, Iss. 9, pp. 1935-1945
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis
Kaijun Wang, Jie Yin, Jiayi Chen, et al.
Phytomedicine (2024) Vol. 128, pp. 155258-155258
Closed Access | Times Cited: 39
An insight into the medicinal attributes of berberine derivatives: A review
Sobhi Gaba, Anjali Saini, Gurpreet Singh, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 38, pp. 116143-116143
Closed Access | Times Cited: 93
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
Nima Hemmat, Zahra Asadzadeh, Noora Karim Ahangar, et al.
Archives of Virology (2021) Vol. 166, Iss. 3, pp. 675-696
Open Access | Times Cited: 80
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
Jean Bousquet, Jean‐Paul Cristol, Heather J. Zar, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 71
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
Finny S. Varghese, Esther van Woudenbergh, Gijs J. Overheul, et al.
Viruses (2021) Vol. 13, Iss. 2, pp. 282-282
Open Access | Times Cited: 71
Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19
Xianfang Tang, Lijun Cai, Yajie Meng, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 69
A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS: A computational and mechanistic study
Zhenzhen Wang, Kun Li, Anish Maskey, et al.
The FASEB Journal (2021) Vol. 35, Iss. 4
Open Access | Times Cited: 57
Neuroprotective potential of berberine in modulating Alzheimer’s disease via multiple signaling pathways
Moazzama Akbar, Anam Shabbir, Kanwal Rehman, et al.
Journal of Food Biochemistry (2021) Vol. 45, Iss. 10
Open Access | Times Cited: 57
Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer
Yi Zhun Zhu, Na Xie, Yilu Chai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 44
Bioactive Compounds from Plant Origin as Natural Antimicrobial Agents for the Treatment of Wound Infections
Katarzyna Pacyga, Paweł Pacyga, Ewa Topola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2100-2100
Open Access | Times Cited: 14
The antibacterial activity of berberine against Cutibacterium acnes: its therapeutic potential in inflammatory acne
Luyao Sun, Qian Yu, Fu Peng, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 8
Anti-dengue therapeutic potential of Tinospora cordifolia and its bioactives
Neetu Singh, Surender Singh Yadav
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118242-118242
Closed Access | Times Cited: 8
Screening of Botanical Drugs Reveals the Potential Anti-human Adenovirus Activity of Berberine
Junyuan Cao, Hao Zhang, Jixiang Zhang, et al.
Antiviral Research (2025), pp. 106105-106105
Open Access | Times Cited: 1
Phytonutrients as a Defensive Barrier Against G Ectodomain Fusion in Chandipura Virus Infection
J. Yadav, Mohammadfesal Ghanchi, Nandan Dixit, et al.
Molecular Biotechnology (2025)
Closed Access | Times Cited: 1
The role of berberine in Covid-19: potential adjunct therapy
Ahmad O. Babalghith, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2003-2016
Open Access | Times Cited: 31
Can Artemisia herba-alba Be Useful for Managing COVID-19 and Comorbidities?
Anamul Hasan, Partha Biswas, Tohmina Afroze Bondhon, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 492-492
Open Access | Times Cited: 29
Nutraceutical Strategies for Suppressing NLRP3 Inflammasome Activation: Pertinence to the Management of COVID-19 and Beyond
Mark F. McCarty, Simon Bernard Iloki Assanga, Lidianys María Lewis Luján, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 47-47
Open Access | Times Cited: 45
Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19
Mehdi Valipour, Afshin Zarghi, Mohammad Ali Ebrahimzadeh, et al.
Cell Cycle (2021) Vol. 20, Iss. 22, pp. 2321-2336
Open Access | Times Cited: 35
Human Papillomavirus and Cellular Pathways: Hits and Targets
Alessandro Medda, Daria Duca, Susanna Chiocca
Pathogens (2021) Vol. 10, Iss. 3, pp. 262-262
Open Access | Times Cited: 33
Different Aspects of Emetine’s Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19
Mehdi Valipour
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 6, pp. 387-399
Open Access | Times Cited: 27
Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms
Hongzhang Ge, Xu Chao, Haitao Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: Promises and challenges
Xiao‐Ying Xu, Yuheng Chen, Xinyu Lu, et al.
Biochemical Pharmacology (2022) Vol. 205, pp. 115279-115279
Open Access | Times Cited: 24
Cancer Pathways Targeted by Berberine: Role of microRNAs
Mansoor Ali, Deepali Mishra, Rana P. Singh
Current Medicinal Chemistry (2024) Vol. 31, Iss. 32, pp. 5178-5198
Closed Access | Times Cited: 5
Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles
Moses Andima, Annette Boese, Pascal Paul, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 5, pp. 1696-1710
Open Access | Times Cited: 5
Improving the Antimicrobial Potency of Berberine for Endodontic Canal Irrigation Using Polymeric Nanoparticles
Célia Marques, Liliana Grenho, Maria Helena Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 786-786
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top